Detalhe da pesquisa
1.
Personality and quality-of-life improvement after apomorphine infusion in Parkinson's disease.
Brain Commun
; 6(3): fcae181, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38846534
2.
Opicapone for Parkinson's disease: clinical evidence and future perspectives.
Neurodegener Dis Manag
; 11(3): 193-206, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745288
3.
A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study.
Parkinsonism Relat Disord
; 89: 128-133, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293534
4.
"Alternating" the Diagnosis after 40 Years of Disease: The Thousand Faces of ATP1A3 Mutation.
Mov Disord Clin Pract
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247386
5.
Clinical and imaging "red flags" for the diagnosis of multiple system atrophy lookalikes.
Parkinsonism Relat Disord
; 112: 105372, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959044
6.
Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis.
Parkinsonism Relat Disord
; 107: 105232, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509623
7.
Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
Parkinsonism Relat Disord
; 116: 105859, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37788512